| __timestamp | Amicus Therapeutics, Inc. | Eli Lilly and Company |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 6620800000 |
| Thursday, January 1, 2015 | 47269000 | 6533000000 |
| Friday, January 1, 2016 | 71151000 | 6452000000 |
| Sunday, January 1, 2017 | 88671000 | 6588100000 |
| Monday, January 1, 2018 | 127200000 | 5975100000 |
| Tuesday, January 1, 2019 | 169861000 | 6213800000 |
| Wednesday, January 1, 2020 | 156407000 | 6121200000 |
| Friday, January 1, 2021 | 192710000 | 6431600000 |
| Saturday, January 1, 2022 | 213041000 | 6440400000 |
| Sunday, January 1, 2023 | 275270000 | 6941200000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, understanding the financial strategies of industry giants is crucial. Over the past decade, Eli Lilly and Amicus Therapeutics have shown distinct trends in their Selling, General, and Administrative (SG&A) expenses. Eli Lilly, a stalwart in the industry, consistently allocated a significant portion of its budget to SG&A, with expenses peaking at approximately $6.9 billion in 2023. This represents a steady increase of about 5% from 2014. In contrast, Amicus Therapeutics, a smaller player, demonstrated a more aggressive growth in SG&A spending, surging by over 1,200% from 2014 to 2023. This strategic investment highlights Amicus's commitment to expanding its market presence. These trends underscore the differing strategies of established versus emerging companies in navigating the pharmaceutical market's complexities.
Eli Lilly and Company and Vertex Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Eli Lilly and Company or Biogen Inc.
Eli Lilly and Company and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and United Therapeutics Corporation
Comparing SG&A Expenses: Eli Lilly and Company vs Madrigal Pharmaceuticals, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Eli Lilly and Company and Apellis Pharmaceuticals, Inc.
Eli Lilly and Company vs ADMA Biologics, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Eli Lilly and Company and Evotec SE
Cost Management Insights: SG&A Expenses for Bristol-Myers Squibb Company and Amicus Therapeutics, Inc.
Comparing SG&A Expenses: Viatris Inc. vs Amicus Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Jazz Pharmaceuticals plc vs Amicus Therapeutics, Inc.
Viking Therapeutics, Inc. or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?